Published in J Allergy Clin Immunol on April 01, 2001
Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol (2008) 1.91
Oxidants and asthma. Thorax (2004) 1.08
Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines. Am J Pathol (2011) 0.90
Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions. Am J Epidemiol (2009) 0.90
Oxidative stress in asthma. World Allergy Organ J (2011) 0.85
Psychological factors in asthma. Allergy Asthma Clin Immunol (2008) 0.82
Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients. PLoS One (2014) 0.77
A mutant of Saccharomyces cerevisiae defective for nuclear fusion. Proc Natl Acad Sci U S A (1976) 9.04
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41
Oligomerization triggers binding of a Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N receptor leading to insertion into membrane microdomains. Biochim Biophys Acta (2004) 2.37
Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89
Benomyl prevents nuclear fusion in Saccharomyces cerevisiae. Mol Gen Genet (1984) 1.88
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Genes involved in the control of nuclear fusion during the sexual cycle of Saccharomyces cerevisiae. Mol Gen Genet (1982) 1.82
Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol (1992) 1.72
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71
Pleural effusion in multiple myeloma. Chest (1994) 1.61
Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem (1999) 1.59
A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Electronic structure of superconducting KC8 and nonsuperconducting LiC6 graphite intercalation compounds: evidence for a graphene-sheet-driven superconducting state. Phys Rev Lett (2011) 1.52
Occupational exposure to electromagnetic fields and the occurrence of brain tumors. An analysis of possible associations. J Occup Med (1985) 1.49
Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49
Mycoplasma hyopneumoniae increases the susceptibility of pigs to experimental Pasteurella multocida pneumonia. Can J Vet Res (1988) 1.45
Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45
Oral allergy syndrome to bird meat associated with egg intolerance. Allergy (1998) 1.38
[Biomedical research in Spain (II). Assessment of the Health Research Fund (FIS) through the research projects funded in 1988-1995 for research centers, colleges, and schools]. Med Clin (Barc) (1999) 1.38
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29
Selection of wine yeasts for growth and fermentation in the presence of ethanol and sucrose. Appl Environ Microbiol (1983) 1.28
Saccharomyces cerevisiae mutant defective in exo-1,3-beta-glucanase production. J Bacteriol (1979) 1.27
Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci (1993) 1.16
Cell cycle-related changes in the conducting properties of r-eag K+ channels. J Cell Biol (1998) 1.15
Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12
Ionic Stress and Osmotic Pressure Induce Different Alterations in the Lipopolysaccharide of a Rhizobium meliloti Strain. Appl Environ Microbiol (1995) 1.11
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Essentiality of Boron for Dinitrogen Fixation in Anabaena sp. PCC 7119. Plant Physiol (1986) 1.10
A calcium signal is involved in heterocyst differentiation in the cyanobacterium Anabaena sp. PCC7120. Microbiology (2004) 1.10
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol (1991) 1.07
Towards an operational system for oil-spill forecast over Spanish waters: initial developments and implementation test. Mar Pollut Bull (2008) 1.07
Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05
Anatomy of the gonadal veins: a reappraisal. Surgery (1991) 1.04
Exopolysaccharide II production is regulated by salt in the halotolerant strain Rhizobium meliloti EFB1. Appl Environ Microbiol (1998) 1.03
Protection circuits for ultrasound applications. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 1.03
Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res (2000) 1.03
Anisotropic electron-phonon coupling and dynamical nesting on the graphene sheets in superconducting CaC6 using angle-resolved photoemission spectroscopy. Phys Rev Lett (2009) 1.02
Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (1999) 1.02
Invasive colitis and hepatitis due to previously uncharacterized spirochetes in patients with advanced human immunodeficiency virus infection. Clin Infect Dis (1995) 1.01
Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol (2001) 1.01
Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol (1998) 1.00
Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus. Br J Pharmacol (1997) 0.98
Use of recombinant aequorin to study calcium homeostasis and monitor calcium transients in response to heat and cold shock in cyanobacteria. Plant Physiol (2000) 0.98
Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96
In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol (1998) 0.96
Boron Protection for O(2) Diffusion in Heterocysts of Anabaena sp. PCC 7119. Plant Physiol (1988) 0.96
Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95
Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95
Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95
Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology (1992) 0.95
Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol (1992) 0.94
Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine (2000) 0.91
Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res (1989) 0.90
Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages. Biochem J (1989) 0.90
A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J Virol Methods (1998) 0.89
A method for determining the position and size of optimal sequence regions for phylogenetic analysis. J Mol Evol (1995) 0.89
p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem (1998) 0.89
Risk of hyperamylasemia and acute pancreatitis after double-balloon enteroscopy: a prospective study. Endoscopy (2011) 0.89
[Pulmonary sequestration with esophagobronchial fistula. Presentation of 2 cases and a review of the literature]. An Esp Pediatr (1989) 0.89
Allergen-specific nasal provocation testing: review by the rhinoconjunctivitis committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol (2011) 0.89
Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol (2000) 0.88
Oleocanthal inhibits proliferation and MIP-1α expression in human multiple myeloma cells. Curr Med Chem (2013) 0.88
Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells. Eur J Pharmacol (2001) 0.88
NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett (1999) 0.88
Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett (1985) 0.87
Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol (1999) 0.87
Fixation of mutations at the VP1 gene of foot-and-mouth disease virus. Can quasispecies define a transient molecular clock? Gene (1991) 0.86
Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology (1994) 0.86
A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J Gen Virol (1996) 0.86
Leptin in joint and bone diseases: new insights. Curr Med Chem (2013) 0.86
Honeymoon rhinitis. Allergy (2001) 0.85
Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res (1993) 0.85
Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions. J Virol (1994) 0.85
Exposure to inhaled particulate matter activates early markers of oxidative stress, inflammation and unfolded protein response in rat striatum. Toxicol Lett (2013) 0.84
A computer program for the design of PCR primers for diagnosis of highly variable genomes. J Virol Methods (1993) 0.84
Enhanced diagnosis of pollen allergy using specific immunoglobulin E determination to detect major allergens and panallergens. J Investig Allergol Clin Immunol (2011) 0.84
An antibody-based ELISA for quantification of Ani s 1, a major allergen from Anisakis simplex. Parasitology (2008) 0.84
Use of the polyene antibiotic N-glycosyl-polifungin in counterselecting yeast mutants. Mutat Res (1981) 0.83
Genetic and biochemical study of threonine-overproducing mutants of Saccharomyces cerevisiae. Mol Cell Biol (1982) 0.83
Branchio-oto-renal syndrome: incidence in three generations of a family. J Pediatr Surg (1993) 0.83
Molecular epidemiology of foot-and-mouth disease virus type O. J Gen Virol (1993) 0.83
Coexistence of cooperators and defectors in well mixed populations mediated by limiting resources. Phys Rev Lett (2012) 0.83
Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal (2001) 0.83
Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology (1991) 0.83
Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns. J Virol Methods (1993) 0.83
[Congenital segmental dilatation of the colon]. Cir Pediatr (1989) 0.83
Development of a sandwich-type ELISA for measuring Pla a 1, the major allergen of Platanus acerifolia pollen. Int Arch Allergy Immunol (2005) 0.83
Systemic polyarteritis nodosa as the initial manifestation of a gastric adenocarcinoma. J Intern Med (1994) 0.82
Misreporting of maternal mortality in Puerto Rico. Bol Asoc Med P R (1990) 0.82
Peripheral blood T lymphocytes in seasonal bronchial asthma. Allergy (1995) 0.82
Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. Exp Cell Res (2001) 0.82
Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions. Antiviral Res (1999) 0.82
Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem (1999) 0.82
Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. J Gen Virol (2003) 0.82